RESPIRATORY INTRODUCTION OF ACTIVATED PROTEIN C IN INFLAMMATORY CONDITIONS INVOLVING RESPIRATORY TRACT

摘要

FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to pharmaceutical industry and represents using human activated protein C or biologically active homolog being more than 90 per cent identical to activated protein C for preparing a single drug effective for treating or reducing a risk of extravascular fibrin accumulation in the human alveolar or bronchoalveolar spaces by the intra-tracheal, intra-alveolar or intra-bronchial introduction through the respiratory passage.EFFECT: invention provides the effective inhibition of extravascular fibrin accumulation.14 cl, 2 ex